20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T7581 | Voxelotor | GBT 440 | Others |
Voxelotor (GBT 440) is an inhibitor of sickle hemoglobin (HbS). | |||
T21652 | RN-1 dihydrochloride | Histone Demethylase , MAO | |
RN-1 dihydrochloride is an effective and selective irreversible inhibitor of lysine-specific demethylase 1 (LSD1, IC50 = 70 nM). | |||
T35044 | Velaresol | BW 12C79,BW 12C,BW-12C79,BW12C79,BW-12C | |
Velaresol (BW12C, BW12C79) is an oxygenated hemoglobin stabilizer that, in addition to stabilizing oxygenated hemoglobin, protects sickle cells from calcium-mediated dehydration. | |||
T77399 | Crizanlizumab | ADAKVEO,SEG-101 | Others |
Crizanlizumab (Adakveo) is a humanized monoclonal antibody against P-selectin for the prevention of pain crises in sickle cell disease. | |||
T3528 | Senicapoc | ICA-17043 | Potassium Channel |
Senicapoc (ICA-17043) is a potent inhibitor of the Gardos channel and ameliorates RBC dehydration in the SAD mouse. Senicapoc blocked Ca2+-induced rubidium flux from human RBCs with an IC50 value of 11 ± 2 nM (CLT IC50 =... | |||
TN2719 | 2',4'-Dihydroxy-6'-methoxyacetophenone | Antibacterial | |
2',4'-Dihydroxy-6'-methoxyacetophenone is a phenolic acetophenone extracted from Leguminosae and Asteraceae with antimicrobial activity and can be used in the synthesis of pyran-sickle. | |||
T8074 | Esafosfan trisodium | Fosfructose trisodium,D-Fructose-1,6-diphosphate trisodium salt octahydrate,FDP trisodium,Diphosphofructose trisodium | Others , Endogenous Metabolite |
Esafosfan trisodium (FDP trisodium) is a cytoprotective natural sugar phosphate for the potential treatment of sickle cell anemia, cardiovascular ischemia and asthma. It acts by stimulating anaerobic glycolysis which gen... | |||
T21389 | Enprofylline | Enprofilina,3-propylxanthine,3-n-Propylxanthine,Enprofyllinum | Others |
Enprofylline (Enprofilina), a bronchodilator, acts primarily as a competitive nonselective phosphodiesterase inhibitor. Enprofylline is used in asthma, chronic obstructive pulmonary disease, and in the management of sick... | |||
T2044 | Varespladib | LY315920 | Phospholipase |
Varespladib (LY315920), a specific and effective human non-pancreatic secretory phospholipase A2 (hnsPLA) inhibitor(IC50=7 nM), has been investigated for the treatment and prevention of sickle cell disease, vaso-occlusiv... | |||
T61833 | Tovinontrine | IMR-687 | PDE |
Tovinontrine (IMR-687) (IMR-687) is a potent and selective inhibitor of phosphodiesterase-9 (PDE9), designed to target sickle cell disease treatment. It exhibits high efficacy, with IC 50 values of 8.19 nM and 9.99 nM fo... | |||
T3228 | Fosfructose | D-fructose-1,6-diphosphate,Betulanonaprenol,4937-84-2,Diphosphofructose,Fructose 1,6-diphosphate,D-fructofuranose 1,6-bisphosphate,Esafosfan | Others , Endogenous Metabolite |
D-fructose-1,6-diphosphate (D-fructose-1,6-diphosphate), also known as Fosfructose, is a cytoprotective natural sugar phosphate. It functions by promoting anaerobic glycolysis, which generates adenosine triphosphate (ATP... | |||
T16478 | PF-04447943 | PF 04447943,Edelinontrine,PF04447943 | PDE |
PF-04447943 (Edelinontrine) is a potent and selective phosphodiesterase 9A inhibitor with an IC50 of 12 nM, which is 78-fold more selective than that used for other PDE family members (IC50>1000 nM).PF-04447943 exhibits ... | |||
T33730 | N-Phenylacetylphenylalanine | ||
N-Phenylacetylphenylalanine is a biaromatic agent with properties that make them suitable candidates for the treatment of sickle cell disease. | |||
T26095 | Rivipansel | GMI1070,GMI-1070,PF 06460031,GMI 1070,PF-06460031 | |
Rivipansel is a glycomimetic compound. It acts as a pan-selectin antagonist and reverses acute vascular occlusions in sickle cell mice. | |||
T39809 | PRMT5-IN-14 | PRMT5-IN-14 | |
PRMT5-IN-14 is a PRMT5 inhibitor to treat cancer, sickle cell, and hereditary persistence of foetal hemoglobin (HPFH) mutations. | |||
T71292 | Rivipansel sodium | ||
Rivipansel sodium is a glycomimetic drug candidate that acts as a pan-selectin antagonist and reverses acute vascular occlusions in sickle cell mice. | |||
T40154 | FTX-6058 | ||
FTX-6058 is a potent orally active inhibitor targeting Embryonic Ectoderm Development (EED). It effectively induces HbF protein expression in both cell and murine models. This compound holds significant potential for res... | |||
T39441 | L-Arginine-15N4 hydrochloride | L-Arginine-15N4 hydrochloride,(S)-(+)-Arginine-15N4 hydrochloride | |
L-Arginine-15N4 ((S)-(+)-Arginine-15N4) hydrochloride, the 15N-labeled variant of L-Arginine hydrochloride ((S)-(+)-Arginine hydrochloride), serves as the nitrogen donor in the synthesis of nitric oxide. This potent vaso... | |||
T40155 | FTX-6058 hydrochloride | ||
FTX-6058 hydrochloride is a potent and orally active inhibitor of Embryonic Ectoderm Development (EED), with the ability to induce HbF protein expression in both cell and murine models. This compound is particularly valu... | |||
T70614 | SLR080811 HCl | ||
SLR080811 is a SphK inhibitor. Sphingosine-1-phosphate (S1P) is a ubiquitous, endogenous small molecule that is synthesized by two isoforms of sphingosine kinase (SphK1 and 2). Intervention of the S1P signaling pathway h... |